Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Generic Drugs Market 2018, Forecast to 2023

Publisher Name :
Date: 14-Jun-2018
No. of pages: 145

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Scope of the Report:

This report focuses on the Generic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The global average gross margin of generic drugs is in the decreasing trend, from 45.19% in 2011 to 43.56% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.

The classification of generic drugs includes simple generic drugs, super generic drugs and biosimilars. And the proportion of simple generic drugs in 2015 is about 80% and the proportion is in decreasing trend from 2011 to 2015. The super generic drugs in 2015 are about 18.7% and the proportion is in increasing trend from 2011 to 2015.

North America region is the largest supplier of generic drugs, with a revenue market share nearly 31.5% in 2015. Europe is the second largest supplier of generic drugs, enjoying revenue market share nearly 26.5% in 2015, India is also an important areas, and with the revenue market share is 22.8% in 2015.

The worldwide market for Generic Drugs is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 369400 million US$ in 2023, from 210800 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Teva

- Novartis - Sandoz

- Mylan

- Sun Pharmaceutical

- Aspen

- Fresenius Kabi

- Pfizer (Hospira)

- Sanofi

- Aurobindo

- Lupin

- Dr. Reddy's

- Apotex

- Cipla

- ENDO (Par Pharmaceutical)

- Stada Arzneimittel

- Krka Group

- Nichi-Iko Pharmaceutical

- Valeant

- Zydus Cadila

- Hikma

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Simple Generic Drugs

- Super Generic Drugs

- Biosimilars

Market Segment by Applications, can be divided into

- CNS

- Cardiovascular

- Genitourinary/Hormonal Drugs

- Respiratory

- Rheumatology

- Diabetes

- Oncology

- Others

There are 15 Chapters to deeply display the global Generic Drugs market.

Chapter 1, to describe Generic Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Generic Drugs, with sales, revenue, and price of Generic Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Generic Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Generic Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Generic Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Generic Drugs Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Generic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Simple Generic Drugs
1.2.2 Super Generic Drugs
1.2.3 Biosimilars
1.3 Market Analysis by Applications
1.3.1 CNS
1.3.2 Cardiovascular
1.3.3 Genitourinary/Hormonal Drugs
1.3.4 Respiratory
1.3.5 Rheumatology
1.3.6 Diabetes
1.3.7 Oncology
1.3.8 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.1.1 Teva Description
2.1.1.2 Teva Headquarter, Main Business and Finance Overview
2.1.2 Teva Generic Drugs Product Introduction
2.1.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.1.2.2 Generic Drugs Product Information
2.1.3 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Teva Generic Drugs Market Share in 2017
2.2 Novartis - Sandoz
2.2.1 Business Overview
2.2.1.1 Novartis - Sandoz Description
2.2.1.2 Novartis - Sandoz Headquarter, Main Business and Finance Overview
2.2.2 Novartis - Sandoz Generic Drugs Product Introduction
2.2.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.2.2.2 Generic Drugs Product Information
2.2.3 Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Novartis - Sandoz Generic Drugs Market Share in 2017
2.3 Mylan
2.3.1 Business Overview
2.3.1.1 Mylan Description
2.3.1.2 Mylan Headquarter, Main Business and Finance Overview
2.3.2 Mylan Generic Drugs Product Introduction
2.3.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.3.2.2 Generic Drugs Product Information
2.3.3 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Mylan Generic Drugs Market Share in 2017
2.4 Sun Pharmaceutical
2.4.1 Business Overview
2.4.1.1 Sun Pharmaceutical Description
2.4.1.2 Sun Pharmaceutical Headquarter, Main Business and Finance Overview
2.4.2 Sun Pharmaceutical Generic Drugs Product Introduction
2.4.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.4.2.2 Generic Drugs Product Information
2.4.3 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Sun Pharmaceutical Generic Drugs Market Share in 2017
2.5 Aspen
2.5.1 Business Overview
2.5.1.1 Aspen Description
2.5.1.2 Aspen Headquarter, Main Business and Finance Overview
2.5.2 Aspen Generic Drugs Product Introduction
2.5.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.5.2.2 Generic Drugs Product Information
2.5.3 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Aspen Generic Drugs Market Share in 2017
2.6 Fresenius Kabi
2.6.1 Business Overview
2.6.1.1 Fresenius Kabi Description
2.6.1.2 Fresenius Kabi Headquarter, Main Business and Finance Overview
2.6.2 Fresenius Kabi Generic Drugs Product Introduction
2.6.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.6.2.2 Generic Drugs Product Information
2.6.3 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Fresenius Kabi Generic Drugs Market Share in 2017
2.7 Pfizer (Hospira)
2.7.1 Business Overview
2.7.1.1 Pfizer (Hospira) Description
2.7.1.2 Pfizer (Hospira) Headquarter, Main Business and Finance Overview
2.7.2 Pfizer (Hospira) Generic Drugs Product Introduction
2.7.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.7.2.2 Generic Drugs Product Information
2.7.3 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Pfizer (Hospira) Generic Drugs Market Share in 2017
2.8 Sanofi
2.8.1 Business Overview
2.8.1.1 Sanofi Description
2.8.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.8.2 Sanofi Generic Drugs Product Introduction
2.8.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.8.2.2 Generic Drugs Product Information
2.8.3 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Sanofi Generic Drugs Market Share in 2017
2.9 Aurobindo
2.9.1 Business Overview
2.9.1.1 Aurobindo Description
2.9.1.2 Aurobindo Headquarter, Main Business and Finance Overview
2.9.2 Aurobindo Generic Drugs Product Introduction
2.9.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.9.2.2 Generic Drugs Product Information
2.9.3 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Aurobindo Generic Drugs Market Share in 2017
2.10 Lupin
2.10.1 Business Overview
2.10.1.1 Lupin Description
2.10.1.2 Lupin Headquarter, Main Business and Finance Overview
2.10.2 Lupin Generic Drugs Product Introduction
2.10.2.1 Generic Drugs Production Bases, Sales Regions and Major Competitors
2.10.2.2 Generic Drugs Product Information
2.10.3 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Lupin Generic Drugs Market Share in 2017
2.11 Dr. Reddy's
2.11.1 Business Overview
2.11.2 Dr. Reddy's Generic Drugs Product Introduction
2.11.3 Dr. Reddy's Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Apotex
2.12.1 Business Overview
2.12.2 Apotex Generic Drugs Product Introduction
2.12.3 Apotex Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Cipla
2.13.1 Business Overview
2.13.2 Cipla Generic Drugs Product Introduction
2.13.3 Cipla Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 ENDO (Par Pharmaceutical)
2.14.1 Business Overview
2.14.2 ENDO (Par Pharmaceutical) Generic Drugs Product Introduction
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Stada Arzneimittel
2.15.1 Business Overview
2.15.2 Stada Arzneimittel Generic Drugs Product Introduction
2.15.3 Stada Arzneimittel Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Krka Group
2.16.1 Business Overview
2.16.2 Krka Group Generic Drugs Product Introduction
2.16.3 Krka Group Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Nichi-Iko Pharmaceutical
2.17.1 Business Overview
2.17.2 Nichi-Iko Pharmaceutical Generic Drugs Product Introduction
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Valeant
2.18.1 Business Overview
2.18.2 Valeant Generic Drugs Product Introduction
2.18.3 Valeant Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Zydus Cadila
2.19.1 Business Overview
2.19.2 Zydus Cadila Generic Drugs Product Introduction
2.19.3 Zydus Cadila Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Hikma
2.20.1 Business Overview
2.20.2 Hikma Generic Drugs Product Introduction
2.20.3 Hikma Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Generic Drugs Market Competition, by Manufacturer
3.1 Global Generic Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Generic Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Generic Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Generic Drugs Manufacturer Market Share in 2017
3.4.2 Top 5 Generic Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Generic Drugs Market Analysis by Regions
4.1 Global Generic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Generic Drugs Sales by Regions (2013-2018)
4.1.2 Global Generic Drugs Revenue by Regions (2013-2018)
4.2 North America Generic Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Generic Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Generic Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Generic Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Generic Drugs Sales, Revenue and Growth Rate (2013-2018)
5 North America Generic Drugs by Countries, Type, Application and Manufacturers
5.1 North America Generic Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Generic Drugs Sales by Countries (2013-2018)
5.1.2 North America Generic Drugs Revenue by Countries (2013-2018)
5.1.3 United States Generic Drugs Sales and Growth Rate (2013-2018)
5.1.4 Canada Generic Drugs Sales and Growth Rate (2013-2018)
5.1.5 Mexico Generic Drugs Sales and Growth Rate (2013-2018)
5.2 North America Generic Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Generic Drugs Sales by Manufacturers (2016-2017)
5.2.2 North America Generic Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Generic Drugs Sales and Sales Share by Type (2013-2018)
5.3.2 North America Generic Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Generic Drugs Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Generic Drugs Sales and Sales Share by Application (2013-2018)
5.4.2 North America Generic Drugs Revenue and Revenue Share by Application (2013-2018)
6 Europe Generic Drugs by Countries, Type, Application and Manufacturers
6.1 Europe Generic Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Generic Drugs Sales by Countries (2013-2018)
6.1.2 Europe Generic Drugs Revenue by Countries (2013-2018)
6.1.3 Germany Generic Drugs Sales and Growth Rate (2013-2018)
6.1.4 UK Generic Drugs Sales and Growth Rate (2013-2018)
6.1.5 France Generic Drugs Sales and Growth Rate (2013-2018)
6.1.6 Russia Generic Drugs Sales and Growth Rate (2013-2018)
6.1.7 Italy Generic Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Generic Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Generic Drugs Sales by Manufacturers (2016-2017)
6.2.2 Europe Generic Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Generic Drugs Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Generic Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Generic Drugs Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Generic Drugs Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Generic Drugs Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Generic Drugs by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Generic Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Generic Drugs Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Generic Drugs Revenue by Countries (2013-2018)
7.1.3 China Generic Drugs Sales and Growth Rate (2013-2018)
7.1.4 Japan Generic Drugs Sales and Growth Rate (2013-2018)
7.1.5 Korea Generic Drugs Sales and Growth Rate (2013-2018)
7.1.6 India Generic Drugs Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Generic Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Generic Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Generic Drugs Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Generic Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Generic Drugs Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Generic Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Generic Drugs Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Generic Drugs Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Generic Drugs Revenue and Revenue Share by Application (2013-2018)
8 South America Generic Drugs by Countries, Type, Application and Manufacturers
8.1 South America Generic Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Generic Drugs Sales by Countries (2013-2018)
8.1.2 South America Generic Drugs Revenue by Countries (2013-2018)
8.1.3 Brazil Generic Drugs Sales and Growth Rate (2013-2018)
8.1.4 Argentina Generic Drugs Sales and Growth Rate (2013-2018)
8.1.5 Colombia Generic Drugs Sales and Growth Rate (2013-2018)
8.2 South America Generic Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Generic Drugs Sales by Manufacturers (2016-2017)
8.2.2 South America Generic Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Generic Drugs Sales and Sales Share by Type (2013-2018)
8.3.2 South America Generic Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Generic Drugs Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Generic Drugs Sales and Sales Share by Application (2013-2018)
8.4.2 South America Generic Drugs Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Generic Drugs by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Generic Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Generic Drugs Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Generic Drugs Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Generic Drugs Sales and Growth Rate (2013-2018)
9.1.4 UAE Generic Drugs Sales and Growth Rate (2013-2018)
9.1.5 Egypt Generic Drugs Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Generic Drugs Sales and Growth Rate (2013-2018)
9.1.7 South Africa Generic Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Generic Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Generic Drugs Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Generic Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Generic Drugs Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Generic Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Generic Drugs Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Generic Drugs Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Generic Drugs Revenue and Revenue Share by Application (2013-2018)
10 Global Generic Drugs Market Segment by Type
10.1 Global Generic Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Generic Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Generic Drugs Revenue and Market Share by Type (2013-2018)
10.2 Simple Generic Drugs Sales Growth and Price
10.2.1 Global Simple Generic Drugs Sales Growth (2013-2018)
10.2.2 Global Simple Generic Drugs Price (2013-2018)
10.3 Super Generic Drugs Sales Growth and Price
10.3.1 Global Super Generic Drugs Sales Growth (2013-2018)
10.3.2 Global Super Generic Drugs Price (2013-2018)
10.4 Biosimilars Sales Growth and Price
10.4.1 Global Biosimilars Sales Growth (2013-2018)
10.4.2 Global Biosimilars Price (2013-2018)
11 Global Generic Drugs Market Segment by Application
11.1 Global Generic Drugs Sales Market Share by Application (2013-2018)
11.2 CNS Sales Growth (2013-2018)
11.3 Cardiovascular Sales Growth (2013-2018)
11.4 Genitourinary/Hormonal Drugs Sales Growth (2013-2018)
11.5 Respiratory Sales Growth (2013-2018)
11.6 Rheumatology Sales Growth (2013-2018)
11.7 Diabetes Sales Growth (2013-2018)
11.8 Oncology Sales Growth (2013-2018)
11.9 Others Sales Growth (2013-2018)
12 Generic Drugs Market Forecast (2018-2023)
12.1 Global Generic Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Generic Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Generic Drugs Market Forecast (2018-2023)
12.2.2 Europe Generic Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Generic Drugs Market Forecast (2018-2023)
12.2.4 South America Generic Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Generic Drugs Market Forecast (2018-2023)
12.3 Generic Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Generic Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Generic Drugs Market Share Forecast by Type (2018-2023)
12.4 Generic Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Generic Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Generic Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Generic Drugs Picture
Table Product Specifications of Generic Drugs
Figure Global Generic Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Generic Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Generic Drugs by Types in 2017
Figure Simple Generic Drugs Picture
Table Major Manufacturers of Simple Generic Drugs
Figure Super Generic Drugs Picture
Table Major Manufacturers of Super Generic Drugs
Figure Biosimilars Picture
Table Major Manufacturers of Biosimilars
Figure Generic Drugs Sales Market Share by Applications in 2017
Figure CNS Picture
Figure Cardiovascular Picture
Figure Genitourinary/Hormonal Drugs Picture
Figure Respiratory Picture
Figure Rheumatology Picture
Figure Diabetes Picture
Figure Oncology Picture
Figure Others Picture
Figure United States Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Generic Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Teva Generic Drugs Product
Table Teva Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Generic Drugs Sales Market Share in 2017
Figure Global Teva Generic Drugs Revenue Market Share in 2017
Table Novartis - Sandoz Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis - Sandoz Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Novartis - Sandoz Generic Drugs Product
Table Novartis - Sandoz Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis - Sandoz Generic Drugs Sales Market Share in 2017
Figure Global Novartis - Sandoz Generic Drugs Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Mylan Generic Drugs Product
Table Mylan Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Generic Drugs Sales Market Share in 2017
Figure Global Mylan Generic Drugs Revenue Market Share in 2017
Table Sun Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Sun Pharmaceutical Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Sun Pharmaceutical Generic Drugs Product
Table Sun Pharmaceutical Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sun Pharmaceutical Generic Drugs Sales Market Share in 2017
Figure Global Sun Pharmaceutical Generic Drugs Revenue Market Share in 2017
Table Aspen Headquarter, Established, Main Business and Finance Overview (2017)
Table Aspen Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Aspen Generic Drugs Product
Table Aspen Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aspen Generic Drugs Sales Market Share in 2017
Figure Global Aspen Generic Drugs Revenue Market Share in 2017
Table Fresenius Kabi Headquarter, Established, Main Business and Finance Overview (2017)
Table Fresenius Kabi Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Fresenius Kabi Generic Drugs Product
Table Fresenius Kabi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Fresenius Kabi Generic Drugs Sales Market Share in 2017
Figure Global Fresenius Kabi Generic Drugs Revenue Market Share in 2017
Table Pfizer (Hospira) Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer (Hospira) Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Pfizer (Hospira) Generic Drugs Product
Table Pfizer (Hospira) Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer (Hospira) Generic Drugs Sales Market Share in 2017
Figure Global Pfizer (Hospira) Generic Drugs Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Sanofi Generic Drugs Product
Table Sanofi Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Generic Drugs Sales Market Share in 2017
Figure Global Sanofi Generic Drugs Revenue Market Share in 2017
Table Aurobindo Headquarter, Established, Main Business and Finance Overview (2017)
Table Aurobindo Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Aurobindo Generic Drugs Product
Table Aurobindo Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aurobindo Generic Drugs Sales Market Share in 2017
Figure Global Aurobindo Generic Drugs Revenue Market Share in 2017
Table Lupin Headquarter, Established, Main Business and Finance Overview (2017)
Table Lupin Generic Drugs Production Bases, Sales Regions and Major Competitors
Table Lupin Generic Drugs Product
Table Lupin Generic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Lupin Generic Drugs Sales Market Share in 2017
Figure Global Lupin Generic Drugs Revenue Market Share in 2017
Table Dr. Reddy's
Table Dr. Reddy's Generic Drugs
Table Apotex
Table Apotex Generic Drugs
Table Cipla
Table Cipla Generic Drugs
Table ENDO (Par Pharmaceutical)
Table ENDO (Par Pharmaceutical) Generic Drugs
Table Stada Arzneimittel
Table Stada Arzneimittel Generic Drugs
Table Krka Group
Table Krka Group Generic Drugs
Table Nichi-Iko Pharmaceutical
Table Nichi-Iko Pharmaceutical Generic Drugs
Table Valeant
Table Valeant Generic Drugs
Table Zydus Cadila
Table Zydus Cadila Generic Drugs
Table Hikma
Table Hikma Generic Drugs
Table Global Generic Drugs Sales by Manufacturer (2016-2017)
Figure Global Generic Drugs Sales Market Share by Manufacturer in 2016
Figure Global Generic Drugs Sales Market Share by Manufacturer in 2017
Table Global Generic Drugs Revenue by Manufacturer (2016-2017)
Figure Global Generic Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Generic Drugs Revenue Market Share by Manufacturer in 2017
Table Global Generic Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Generic Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Generic Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Generic Drugs Sales and Growth Rate (2013-2018)
Figure Global Generic Drugs Revenue and Growth Rate (2013-2018)
Table Global Generic Drugs Sales by Regions (2013-2018)
Table Global Generic Drugs Sales Market Share by Regions (2013-2018)
Table Global Generic Drugs Revenue by Regions (2013-2018)
Figure Global Generic Drugs Revenue Market Share by Regions in 2013
Figure Global Generic Drugs Revenue Market Share by Regions in 2017
Figure North America Generic Drugs Sales and Growth Rate (2013-2018)
Figure North America Generic Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Generic Drugs Sales and Growth Rate (2013-2018)
Figure Europe Generic Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Generic Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Generic Drugs Revenue and Growth Rate (2013-2018)
Figure South America Generic Drugs Sales and Growth Rate (2013-2018)
Figure South America Generic Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Generic Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Generic Drugs Revenue and Growth Rate (2013-2018)
Figure North America Generic Drugs Revenue and Growth Rate (2013-2018)
Table North America Generic Drugs Sales by Countries (2013-2018)
Table North America Generic Drugs Sales Market Share by Countries (2013-2018)
Figure North America Generic Drugs Sales Market Share by Countries in 2013
Figure North America Generic Drugs Sales Market Share by Countries in 2017
Table North America Generic Drugs Revenue by Countries (2013-2018)
Table North America Generic Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Generic Drugs Revenue Market Share by Countries in 2013
Figure North America Generic Drugs Revenue Market Share by Countries in 2017
Figure United States Generic Drugs Sales and Growth Rate (2013-2018)
Figure Canada Generic Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Generic Drugs Sales and Growth Rate (2013-2018)
Table North America Generic Drugs Sales by Manufacturer (2016-2017)
Figure North America Generic Drugs Sales Market Share by Manufacturer in 2016
Figure North America Generic Drugs Sales Market Share by Manufacturer in 2017
Table North America Generic Drugs Revenue by Manufacturer (2016-2017)
Figure North America Generic Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Generic Drugs Revenue Market Share by Manufacturer in 2017
Table North America Generic Drugs Sales by Type (2013-2018)
Table North America Generic Drugs Sales Share by Type (2013-2018)
Table North America Generic Drugs Revenue by Type (2013-2018)
Table North America Generic Drugs Revenue Share by Type (2013-2018)
Table North America Generic Drugs Sales by Application (2013-2018)
Table North America Generic Drugs Sales Share by Application (2013-2018)
Table North America Generic Drugs Revenue by Application (2013-2018)
Table North America Generic Drugs Revenue Share by Application (2013-2018)
Figure Europe Generic Drugs Revenue and Growth Rate (2013-2018)
Table Europe Generic Drugs Sales by Countries (2013-2018)
Table Europe Generic Drugs Sales Market Share by Countries (2013-2018)
Table Europe Generic Drugs Revenue by Countries (2013-2018)
Figure Europe Generic Drugs Revenue Market Share by Countries in 2016
Figure Europe Generic Drugs Revenue Market Share by Countries in 2017
Figure Germany Generic Drugs Sales and Growth Rate (2013-2018)
Figure UK Generic Drugs Sales and Growth Rate (2013-2018)
Figure France Generic Drugs Sales and Growth Rate (2013-2018)
Figure Russia Generic Drugs Sales and Growth Rate (2013-2018)
Figure Italy Generic Drugs Sales and Growth Rate (2013-2018)
Table Europe Generic Drugs Sales by Manufacturer (2016-2017)
Figure Europe Generic Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Generic Drugs Sales Market Share by Manufacturer in 2017
Table Europe Generic Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Generic Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Generic Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Generic Drugs Sales by Type (2013-2018)
Table Europe Generic Drugs Sales Share by Type (2013-2018)
Table Europe Generic Drugs Revenue by Type (2013-2018)
Table Europe Generic Drugs Revenue Share by Type (2013-2018)
Table Europe Generic Drugs Sales by Application (2013-2018)
Table Europe Generic Drugs Sales Share by Application (2013-2018)
Table Europe Generic Drugs Revenue by Application (2013-2018)
Table Europe Generic Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Generic Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Generic Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Generic Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Generic Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Generic Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Generic Drugs Revenue Market Share by Countries 2017
Figure China Generic Drugs Sales and Growth Rate (2013-2018)
Figure Japan Generic Drugs Sales and Growth Rate (2013-2018)
Figure Korea Generic Drugs Sales and Growth Rate (2013-2018)
Figure India Generic Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Generic Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Generic Drugs Sales by Manufacturer (2016-2017)
Figu
  • Global Lactulose Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Scope of the Report: This report focuses on the Lactulose in global market, especially i......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Lactulose Market 2018, Forecast to 2023
    Published: 21-Jun-2018        Price: US 4880 Onwards        Pages: 136
    Lactulose a "bifidus factor" is composed of galactose and fructose, which can be produced by the isomerization of lactose. It is a prebiotic carbohydrate which stimulates the growth of health-promoting bacteria in the gastrointestinal tract, it can also be used for the treatment of constipation, hepatic encephalopathy, tumour prevention, and to maintain blood glucose and insulin level. Scope of the Report: This report focuses on the Lactulose in global market, especially i......
  • Global Legal Marijuana Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 132
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes can......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Legal Marijuana Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 132
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes can......
  • Global Deferiprone Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 112
    Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Deferiprone Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 115
    Nerve damages can be caused by either blunt trauma, such as an impact from a fall or from traction injuries from motor vehicle accidents, or sharp trauma, such as direct cuts from a knife. Injury to a nerve can stop signals to and from the brain. Surgical nerve repair involves the exploration of the injured nerve and the removal of injured tissue from the nerve endings. Nerve repair and regeneration product are used through surgical interventions to restore normal function in nerves. ......
  • Global Deferasirox Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 20-Jun-2018        Price: US 3480 Onwards        Pages: 111
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. Scope of the Report: This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Deferasirox Market 2018, Forecast to 2023
    Published: 20-Jun-2018        Price: US 4880 Onwards        Pages: 117
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. Scope of the Report: This report focuses on the Deferasirox in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.......
  • Global Minocycline Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 19-Jun-2018        Price: US 3480 Onwards        Pages: 111
    Minocycline Hydrochloride, also called minocycline HCL, is a broad-spectrum tetracycline antibiotic, and has a broader spectrum than the other members of the group. It is a bacteriostatic antibiotic, classified as a long-acting type. As a result of its long half-life it generally has serum levels 2-4 times that of the simple water-soluble tetracyclines. The CAS Number is 13614-98-7. Scope of the Report: This report focuses on the Minocycline Hydrochloride in global ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs